Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The...
The Biotech company Evaxion Biotech, EVAX, who develop drugs based on AI platforms, is poised to publish data from its phase 1/2a trials of EVX-01 and EVX-02 in the first half of 2021.
According to Yahoo Finance there are currently two analysts with price targets for the share, $18 and $23.
Evaxion is an AI-immunology platform company decoding the human immune...
EVAX - Evaxion
Website: evaxion-biotech.com
Industry: Pharma
Evaxion is an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases.
Evaxion have developed an AI-immunology core technology to deeply understand the biological processes relevant for engaging the immune system...
